Showing posts with label schizophrenia. Show all posts
Showing posts with label schizophrenia. Show all posts

Tuesday, September 20, 2011

Genetic links to schizophrenia?


 Washington, Sep 20 - Scientists claim they are a step closer to unravelling the genetic underpinnings of schizophrenia following the largest genome-wide association research of the disorder ever undertaken.
 An international team of 190 scientists from 135 institutions found significant associations with schizophrenia for five new and two previously implicated locations on the human genome, the 'Nature Genetics' journal reported.

 It has long been recognised that schizophrenia is highly heritable.
 However, this research has pinpointed novel regions of the human genome significantly associated with disease, and confirmed other recently reported genomic regions that may harbour disease-causing genetic variation.

 According to Prof Bryan Mowry from Queensland Brain Institute, a team member, these findings were made possible because of the unprecedented size of the study, with more than 50,000 participants.
 ÒIt provides a solid foundation for beginning to understand the mechanisms underlying the substantial genetic predisposition to schizophrenia,Ó Prof Mowry said.

 Schizophrenia affects 1 in 100 people and its onset is typically in adolescence or early adulthood. Psychosis (comprising hallucinations and delusions) is the hallmark of schizophrenia, but other symptoms such as personal neglect and amotivation are common, as is an increased risk of suicide.

Prof Mowry says that gaining a better understanding of the genetic architecture of schizophrenia will ultimately aid the earlier diagnosis and management of the disorder.

 ÒIf your genetic profile suggests you have a predisposition towards developing schizophrenia, it will be particularly important for you to avoid known environmental risk factors, such as smoking cannabis.

 ÒWe also expect that understanding the biological mechanisms underlying the disorder will lead to more robust therapeutics in future,Ó he said.

 The strongest genome-wide association finding in the study was to single nucleotide polymorphisms (SNPs) in a region containing numerous immune-related genes, suggesting schizophrenia may be triggered by autoimmune responses or infection.

 Another SNP in a region linked to neuronal development was also implicated, suggesting a novel mechanism underlying schizophrenia.

 The study also confirmed genetic overlap between bipolar disorder and schizophrenia, suggesting that these disorders have shared rather than separate roots.

Monday, September 19, 2011

First detailed map of human neuroreceptor 'generated'


 Washington, Sep 19 - Scientists claim to have for the first time generated a detailed map of human neuroreceptor, a breakthrough that may revolutionise the engineering of drugs used to treat diseases like Alzheimer's and schizophrenia.

 A team at the University of Southern California has produced the world's first high-resolution images of the ?7 (Alpha 7) receptor, a molecule responsible for transmitting signals between neurons -- particularly in regions of the brain believed to be associated with learning and memory.

 Using the image, the scientists will be better equipped to design pharmaceuticals specifically to interact with the receptor, instead of blindly using a trial-and-error approach.

 ÒA lot of interest in this work will come from pharmaceutical companies. They really have no clear picture of this. They don't know how or why (their drugs) work,Ó said team member Prof Lin Chen.
 The high-resolution image will also help neuroscience researchers study how these receptors receive and transmit neuronal signals, a question that has puzzled researchers for decades, says the team.

 Developing an image of the ?7 receptor was no simple task, which is partly why it has taken until now to achieve this despite the wide interest in the understanding the receptor's structure. Attempts to decipher neuroreceptors have been ongoing for 30 years.

 ÒThis has been a longstanding challenge. The challenge is twofold,Ó Chen said.
 In the case of ?7, the team engineered a chimera, a Frankenstein molecule sharing about 70 per cent of its structure in common with the ?7 that reacted to stimuli in the same way that natural ?7 does.